Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

987 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.
Tewari KS, Sill MW, Coleman RL, Aghajanian C, Mannel R, DiSilvestro PA, Powell M, Randall LM, Farley J, Rubin SC, Monk BJ. Tewari KS, et al. Among authors: farley j. Gynecol Oncol. 2020 Oct;159(1):79-87. doi: 10.1016/j.ygyno.2020.07.015. Epub 2020 Jul 26. Gynecol Oncol. 2020. PMID: 32723679 Free PMC article. Clinical Trial.
Clinical surveillance of gynecologic cancer patients.
Barnhill D, O'Connor D, Farley J, Teneriello M, Armstrong D, Park R. Barnhill D, et al. Among authors: farley j. Gynecol Oncol. 1992 Sep;46(3):275-80. doi: 10.1016/0090-8258(92)90216-6. Gynecol Oncol. 1992. PMID: 1526504
The role of p27 in endometrial carcinoma.
Nycum LR, Smith LM, Farley JH, Kost ER, Method MW, Birrer MJ. Nycum LR, et al. Among authors: farley jh. Gynecol Oncol. 2001 May;81(2):242-6. doi: 10.1006/gyno.2001.6144. Gynecol Oncol. 2001. PMID: 11330957
Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study.
Darcy KM, Brady WE, McBroom JW, Bell JG, Young RC, McGuire WP, Linnoila RI, Hendricks D, Bonome T, Farley JH; Gynecologic Oncology Group. Darcy KM, et al. Gynecol Oncol. 2008 Dec;111(3):487-95. doi: 10.1016/j.ygyno.2008.08.020. Epub 2008 Oct 2. Gynecol Oncol. 2008. PMID: 18834621 Free PMC article. Clinical Trial.
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
Farley J, Fuchiuji S, Darcy KM, Tian C, Hoskins WJ, McGuire WP, Hanjani P, Warshal D, Greer BE, Belinson J, Birrer MJ. Farley J, et al. Gynecol Oncol. 2009 Jun;113(3):341-7. doi: 10.1016/j.ygyno.2009.02.009. Epub 2009 Mar 9. Gynecol Oncol. 2009. PMID: 19272639 Free PMC article.
987 results